Boglárka Soós

594 total citations
30 papers, 338 citations indexed

About

Boglárka Soós is a scholar working on Rheumatology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Boglárka Soós has authored 30 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Epidemiology and 5 papers in Economics and Econometrics. Recurrent topics in Boglárka Soós's work include Rheumatoid Arthritis Research and Therapies (11 papers), Chronic Disease Management Strategies (7 papers) and Systemic Lupus Erythematosus Research (5 papers). Boglárka Soós is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Chronic Disease Management Strategies (7 papers) and Systemic Lupus Erythematosus Research (5 papers). Boglárka Soós collaborates with scholars based in Hungary, Canada and United States. Boglárka Soós's co-authors include Zoltán Szekanecz, Neil Drummond, Cliff Lindeman, Alexander Singer, John Queenan, Willem F. Lems, Julia Kurzawa, Soroush Shojai, Mohamed A. Osman and Delphine S. Tuot and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Boglárka Soós

27 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boglárka Soós Hungary 10 93 65 45 45 43 30 338
Sergio Iannazzo Italy 14 54 0.6× 48 0.7× 69 1.5× 15 0.3× 55 1.3× 75 455
Xavier Surís Spain 12 76 0.8× 40 0.6× 15 0.3× 21 0.5× 62 1.4× 36 446
Jianyan Long China 11 35 0.4× 150 2.3× 17 0.4× 30 0.7× 80 1.9× 23 510
Anthony Fenton United Kingdom 14 25 0.3× 210 3.2× 47 1.0× 27 0.6× 74 1.7× 21 484
Ajay Dhaygude United Kingdom 14 84 0.9× 328 5.0× 133 3.0× 27 0.6× 40 0.9× 47 677
Carmel Silke Ireland 12 62 0.7× 37 0.6× 20 0.4× 15 0.3× 33 0.8× 24 334
Nicholas Fluck United Kingdom 11 39 0.4× 225 3.5× 43 1.0× 35 0.8× 64 1.5× 20 429
Saugar Maripuri United States 7 54 0.6× 86 1.3× 29 0.6× 33 0.7× 14 0.3× 8 272
H Rosenberg Chile 8 64 0.7× 33 0.5× 77 1.7× 20 0.4× 61 1.4× 24 379
Laura Mariani United States 8 78 0.8× 337 5.2× 51 1.1× 20 0.4× 23 0.5× 20 576

Countries citing papers authored by Boglárka Soós

Since Specialization
Citations

This map shows the geographic impact of Boglárka Soós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boglárka Soós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boglárka Soós more than expected).

Fields of papers citing papers by Boglárka Soós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boglárka Soós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boglárka Soós. The network helps show where Boglárka Soós may publish in the future.

Co-authorship network of co-authors of Boglárka Soós

This figure shows the co-authorship network connecting the top 25 collaborators of Boglárka Soós. A scholar is included among the top collaborators of Boglárka Soós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boglárka Soós. Boglárka Soós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Simon, Diána, Boglárka Soós, Edit Végh, et al.. (2024). Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology. International Journal of Molecular Sciences. 25(6). 3429–3429. 1 indexed citations
3.
Soós, Boglárka, Stephanie Garies, Heather Sharpe, et al.. (2023). Documenting cannabis use in primary care: a descriptive cross-sectional study using electronic medical record data in Alberta, Canada. BMC Research Notes. 16(1). 9–9. 2 indexed citations
4.
Kerekes, György, Attila Hamar, Gábor Tajti, et al.. (2023). Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis. Lara D. Veeken. 62(SI3). SI304–SI312. 6 indexed citations
5.
Gruneir, Andrea, Erik Youngson, Bonnie Dobbs, et al.. (2023). Older persons living with dementia and their use of acute care services over 2 years in Alberta. Canadian Family Physician. 69(2). 114–124.
6.
Horváth, Ágnes, Edit Végh, Boglárka Soós, et al.. (2023). Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis. Frontiers in Medicine. 10. 1226760–1226760.
7.
Johnston, Ian S., Boglárka Soós, Stephanie Garies, et al.. (2022). A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database. BMC Primary Care. 23(1). 128–128. 7 indexed citations
8.
Soós, Boglárka, Attila Hamar, Edit Végh, et al.. (2022). Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach. Frontiers in Medicine. 9. 1011734–1011734. 11 indexed citations
9.
Soós, Boglárka, Ágnes Szentpétery, Hennie G. Raterman, et al.. (2022). Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nature Reviews Rheumatology. 18(5). 249–257. 42 indexed citations
10.
Cave, Andrew, Anh Nguyet Pham, Cliff Lindeman, et al.. (2021). Chronic obstructive pulmonary disease as a risk factor in primary care: a Canadian retrospective cohort study. npj Primary Care Respiratory Medicine. 31(1). 37–37. 7 indexed citations
11.
Hopper, Tammy, et al.. (2021). Development of a case definition for hearing loss in community-based older adults: a cross-sectional validation study. CMAJ Open. 9(3). E796–E801. 2 indexed citations
12.
Szekanecz, Zoltán, Boglárka Soós, Levente Bodoki, et al.. (2020). Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. Autoimmunity Reviews. 19(11). 102658–102658. 14 indexed citations
13.
Cave, Andrew, et al.. (2020). Validating a case definition for adult asthma in primary care electronic medical records. npj Primary Care Respiratory Medicine. 30(1). 24–24. 6 indexed citations
14.
15.
Garies, Stephanie, Brian Forst, Kerry McBrien, et al.. (2019). Achieving quality primary care data: a description of the Canadian Primary Care Sentinel Surveillance Network data capture, extraction, and processing in Alberta. International Journal for Population Data Science. 4(2). 1132–1132. 9 indexed citations
16.
Sarzi‐Puttini, Piercarlo, Daniela Marotto, Roberto Caporali, et al.. (2019). Biosimilars vs originators: Are they the same?. Autoimmunity Reviews. 18(12). 102404–102404. 8 indexed citations
17.
Bello, Aminu K., Paul E. Ronksley, Navdeep Tangri, et al.. (2019). Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study. Kidney International Reports. 4(4). 561–570. 56 indexed citations
18.
Lethebe, Brendan Cord, Tyler Williamson, Stephanie Garies, et al.. (2019). Developing a case definition for type 1 diabetes mellitus in a primary care electronic medical record database: an exploratory study. CMAJ Open. 7(2). E246–E251. 14 indexed citations
19.
Bello, Aminu K., Paul E. Ronksley, Navdeep Tangri, et al.. (2017). A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol. BMJ Open. 7(8). e016267–e016267. 7 indexed citations
20.
Kádár, Gabriella, et al.. (2014). Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseases. Clinical Rheumatology. 33(3). 329–333. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergio Iannazzo Breakdown of academic impact, for papers by Xavier Surís Breakdown of academic impact, for papers by Jianyan Long Breakdown of academic impact, for papers by Anthony Fenton Breakdown of academic impact, for papers by Ajay Dhaygude Breakdown of academic impact, for papers by Carmel Silke Breakdown of academic impact, for papers by Nicholas Fluck Breakdown of academic impact, for papers by Saugar Maripuri Breakdown of academic impact, for papers by H Rosenberg Breakdown of academic impact, for papers by Laura Mariani
Rankless by CCL
2026